Last updated on April 17, 2014 at 1:21 EDT

Latest Morton Printz Stories

2012-09-06 02:32:18

NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced the following additions to its Scientific Advisory Board: Dr. Kevan Herold and Dr. Morton Printz. "These key additions to our Scientific Advisory Board are demonstrative of our progress, and the leading edge therapies for...